Tracy Murphy

1.8k citations

29 papers · 463 indexed · h-index 10

Impact in

Hematology top 5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
Cancer Research
- Cancer Genomics and Diagnostics

Papers in ⓘ

Hematology 22
- Acute Myeloid Leukemia Research 20
- Chronic Myeloid Leukemia Treatments 8
- Multiple Myeloma Research and Treatments 5
Public Health, Environmental and Occupational Health 10
- Acute Lymphoblastic Leukemia research 10

Co-authors: Karen Yee (18 shared papers)Aaron D. Schimmer (18 shared papers)Mark D. Minden (20 shared papers)Steven M. Chan (18 shared papers)Emily Heath (1 shared paper)Liran I. Shlush (2 shared papers)Neal S. Goldstein (1 shared paper)Parinaz Mehdipour (1 shared paper)
Journals: Blood (13 papers)British Journal of Haematology (2 papers)Leukemia (2 papers)Blood Advances (1 paper)Science Advances (1 paper)
Partner nations: Canada United States Australia

In The Last Decade

Tracy Murphy

26 papers receiving 462 citations

Peers

Countries citing papers authored by Tracy Murphy

Since Specialization

Citations

This map shows the geographic impact of Tracy Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tracy Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tracy Murphy more than expected).

Fields of papers citing papers by Tracy Murphy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tracy Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tracy Murphy. The network helps show where Tracy Murphy may publish in the future.

Co-authors

The 25 scholars most cited alongside Tracy Murphy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tracy Murphy Line = papers co-authored together Tracy Murphy links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Biological and clinical consequences of NPM1 mutations in AML Leukemia ·Emily Heath, Steven M. Chan, Mark D. Minden, Tracy Murphy, Liran I. Shlush, Aaron D. Schimmer	2017	125
2	Cytarabine and daunorubicin for the treatment of acute myeloid leukemia Expert Opinion on Pharmacotherapy ·Tracy Murphy, Karen Yee	2017	122
3	The role of DNA-demethylating agents in cancer therapy Pharmacology & Therapeutics ·Parinaz Mehdipour, Tracy Murphy, Daniel D. De Carvalho	2019	33
4	Intraductal Carcinoma Associated With Invasive Carcinoma of the Breast:A Comparison of the Two Lesions With Implications for Intraductal Carcinoma Classification Systems American Journal of Clinical Pathology ·Neal S. Goldstein, Tracy Murphy	1996	29
5	Emerging therapies for acute myeloid leukemia: translating biology into the clinic JCI Insight ·Simon Kavanagh, Tracy Murphy, Arjun Law, Dana Yehudai, Jenny Ho, Stephen Chan, Aaron D. Schimmer	2017	29
6	Measurable residual disease monitoring provides insufficient lead-time to prevent morphologic relapse in the majority of patients with core-binding factor acute myeloid leukemia Haematologica ·Robert Puckrin, Eshetu G. Atenafu, Jaime O. Claudio, Steven M. Chan, Vikas Gupta, Dawn Maze, Caroline McNamara, Tracy Murphy, Andre C. Shuh, Karen Yee, Hassan Sibai, Mark D. Minden, Cuihong Wei, Tracy Stockley, Suzanne Kamel‐Reid, Aaron D. Schimmer	2020	28
7	Anticoagulation prophylaxis reduces venous thromboembolism rate in adult acute lymphoblastic leukaemia treated with asparaginase‐based therapy British Journal of Haematology ·Hassan Sibai, Ruiqi Chen, Xing Liu, Umberto Falcone, Aaron D. Schimmer, Andre C. Schuh, Arjun Law, Caroline McNamara, Dawn Maze, Karen Yee, Mark D. Minden, Steven M. Chan, Vikas Gupta, Tracy Murphy, Naoko Sakurai, Eshetu G. Atenafu, Joseph Brandwein, Jack T Seki	2020	14
8	Enasidenib in Combination with Venetoclax in IDH2-Mutated Myeloid Malignancies: Preliminary Results of the Phase Ib/II Enaven-AML Trial Blood ·Steven M. Chan, Charina Cameron, Séverine Cathelin, Vikas Gupta, Dawn Maze, Mark D. Minden, Tracy Murphy, Aaron D. Schimmer, Andre C. Schuh, Hassan Sibai, Karen Yee, Courtney D. DiNardo, Caroline McNamara	2021	13
9	Preclinical characterization and clinical trial of CFI-400945, a polo-like kinase 4 inhibitor, in patients with relapsed/refractory acute myeloid leukemia and higher-risk myelodysplastic neoplasms Leukemia ·Tracy Murphy, Jacqueline M. Mason, Brian Leber, Mark R. Bray, Steven M. Chan, Vikas Gupta, Dina Khalaf, Dawn Maze, Caroline McNamara, Aaron D. Schimmer, Andre C. Schuh, Hassan Sibai, Michael Trus, Debbie Valiquette, Kylie Martin, Linh Nguyen, Xuan Li, Tak W. Mak, Mark D. Minden, Karen Yee	2023	11
10	Final Results of the Phase Ib/II Study Evaluating Enasidenib in Combination with Venetoclax in Patients with IDH2-Mutated Relapsed/Refractory Myeloid Malignancies Blood ·Guillaume Richard‐Carpentier, Gopila Gupta, Charina Cameron, Séverine Cathelin, Aniket Bankar, Marta Davidson, Vikas Gupta, Dawn Maze, Mark D. Minden, Tracy Murphy, Aaron D. Schimmer, Andre C. Schuh, Hassan Sibai, Karen Yee, Courtney D. DiNardo, Joseph Brandwein, Caroline McNamara, Steven M. Chan	2023	10
11	Impact of preleukemic mutations and their persistence on hematologic recovery after induction chemotherapy for AML Blood Advances ·Tracy Murphy, Jinfeng Zou, Georgina S. Daher-Reyes, Andrea Arruda, Vikas Gupta, Caroline McNamara, Mark D. Minden, Aaron D. Schimmer, Hassan Sibai, Karen Yee, Mariam Korulla, Tracy Stockley, Suzanne Kamel‐Reid, Dawn Maze, Anne Tierens, Scott V. Bratman, Andre C. Schuh, Steven M. Chan	2019	9
12	Integration of intra-sample contextual error modeling for improved detection of somatic mutations from deep sequencing Science Advances ·Sagi Abelson, Andy G.X. Zeng, Ido Nofech-Mozes, Ting Ting Wang, Stanley Ng, Mark D. Minden, Trevor J. Pugh, Philip Awadalla, Liran I. Shlush, Tracy Murphy, Steven M. Chan, John E. Dick, Scott V. Bratman	2020	8
13	Clofarabine in the treatment of poor risk acute myeloid leukaemia Hematological Oncology ·Janusz Krawczyk, Naeem Ansar, Ronan Swords, Tracy Murphy, B. MacDonagh, Teresa Meenaghan, Patrick Hayden, Amjad Hayad, Margaret Murray, Michael O’Dwyer	2009	6
14	Anticoagulation Prophylaxis with Weight-Adjusted Enoxaparin Reduces Rates of Venous Thromboembolism in Patients with Acute Lymphoblastic Leukemia Receiving Asparaginase-Based Intensification Therapy Blood ·Hassan Sibai, Ruiqi Chen, Xing Liu, Aaron D. Schimmer, Andre C. Schuh, Arjun Law, Caroline McNamara, Dawn Maze, Karen Yee, Mark D. Minden, Steven M. Chan, Vikas Gupta, Tracy Murphy, Umberto Falcone, Naoko Sakurai, Joseph Brandwein, Jack T Seki	2018	5
15	Trial in Progress: Feasibility and Validation Study of the LSC17 Score in Acute Myeloid Leukemia Patients Blood ·Tracy Murphy, Stanley Ng, Tong Zhang, Ian King, Andrea Arruda, Jaime O. Claudio, Narmin Ibrahimova, Fiona Ferrera, Chantal Rockwell, Zhibin Lu, Natalie Stickle, Carl Virtanen, Brian Leber, Mitchell Sabloff, Mark D. Minden, Tracy Stockley, Steven M. Chan, Jean Wang	2019	4
16	Preliminary Results from a Phase 1 Study of Cfi-400495, a PLK4 Inhibitor, in Patients with Acute Myeloid Leukemia and High Risk MDS Blood ·Tracy Murphy, Brian Leber, Mark R. Bray, Steven M. Chan, Vikas Gupta, Dina Khalaf, Dawn Maze, Caroline McNamara, Aaron D. Schimmer, Andre C. Schuh, Hassan Sibai, Graham C. Fletcher, Debbie Valiquette, Kylie Martin, Mark D. Minden, Karen Yee	2020	3
17	CPX351 Has Short Remission Duration but Is an Effective Bridge to Allogeneic Transplant in High Risk AML: Results from Canadian Real-World Multi-Centre Study Blood ·Claire Andrews, Taylor Young, Eshetu G. Atenafu, Sarit Assouline, Joseph Brandwein, Steven M. Chan, Signy Chow, Dina Khalaf, Vikas Gupta, Dennis Dong Hwan Kim, Dawn Maze, Mark D. Minden, Caroline McNamara, Tracy Murphy, David Sanford, Aaron D. Schimmer, Andre C. Schuh, Karen Yee, Hassan Sibai	2020	3
18	Combination treatment with CPX‐351 and midostaurin in patients with secondary acute myeloid leukaemia that are FLT3 mutated: three cases and review of literature British Journal of Haematology ·Claire Andrews, Dawn Maze, Tracy Murphy, Hassan Sibai	2020	2
19	Azacitidine and venetoclax for the treatment of accelerated and blast phase myeloproliferative neoplasms and chronic myelomonocytic leukemia: a case series Leukemia & lymphoma ·Alejandro Garcia‐Horton, Dawn Maze, Caroline McNamara, Hassan Sibai, Vikas Gupta, Tracy Murphy	2021	2
20	Risk of Thrombosis in Adult Philadelphia-Positive ALL Treated with an Asparaginase-Free Pediatric-Inspired ALL Regimen with Imatinib Blood ·Ruiqi Chen, Xing Liu, Solaf Kanfar, Dawn Maze, Steven M. Chan, Vikas Gupta, Karen Yee, Mark D. Minden, Aaron D. Schimmer, Andre C. Schuh, Caroline McNamara, Tracy Murphy, Anna Xu, Umberto Falcone, Jack T Seki, Hassan Sibai	2019	1

About Tracy Murphy

Tracy Murphy is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Genetics, Molecular Biology and Cancer Research, having authored 29 papers that have together received 463 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (20 papers), Acute Lymphoblastic Leukemia research (10 papers), Chronic Myeloid Leukemia Treatments (8 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Cancer Genomics and Diagnostics (5 papers), Multiple Myeloma Research and Treatments (5 papers), Microtubule and mitosis dynamics (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Hematology (265 citations), Cancer Research (97 citations), Genetics (68 citations), Molecular Biology (248 citations) and Internal Medicine (13 citations). Tracy Murphy has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Karen Yee, Aaron D. Schimmer, Mark D. Minden, Steven M. Chan, Emily Heath, Liran I. Shlush, Neal S. Goldstein, Parinaz Mehdipour, Daniel D. De Carvalho and Hassan Sibai. Their work appears in journals such as Blood, British Journal of Haematology, Leukemia, Blood Advances and Science Advances.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact